Free Access
Issue
Réanimation
Volume 25, Number 3, Mai 2016
Infectieux
Page(s) 361 - 365
Section Lettre à L’Éditeur / Letter to the Editor
DOI https://doi.org/10.1007/s13546-015-1124-9
Published online 07 October 2015
  • Wertheim HF, Verbrugh HA (2006) Global prevalence of meticillin-resistant Staphylococcus aureus. Lancet 368:1866 [CrossRef] [PubMed] [Google Scholar]
  • Gillet Y, Issartel B, Vanhems P, et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–9 [CrossRef] [PubMed] [Google Scholar]
  • Gillet Y, Vanhems P, Lina G, et al (2007) Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45:315–21 [CrossRef] [PubMed] [Google Scholar]
  • Loffler B, Niemann S, Ehrhardt C, et al (2013) Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. Expert Rev Anti Infect Ther 11:1041–51 [CrossRef] [PubMed] [Google Scholar]
  • de Bentzmann S, Tristan A, Etienne J, et al (2004) Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 190:1506–15 [CrossRef] [PubMed] [Google Scholar]
  • Genestier AL, Michallet MC, Prevost G, et al (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115:3117–27 [CrossRef] [PubMed] [Google Scholar]
  • Gillet Y, Dumitrescu O, Tristan A, et al (2011) Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int J Antimicrob Agents 38:457–64 [CrossRef] [PubMed] [Google Scholar]
  • Konig B, Prevost G, Piemont Y, Konig W (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171:607–13 [CrossRef] [PubMed] [Google Scholar]
  • Stevens DL, Ma Y, Salmi DB, et al (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195:202–11 [CrossRef] [PubMed] [Google Scholar]
  • Chastre J, Blasi F, Masterton RG, et al (2014) European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect 20(Suppl 4):19–36 [CrossRef] [Google Scholar]
  • Carapetis JR, Jacoby P, Carville K, et al (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358–65 [CrossRef] [PubMed] [Google Scholar]
  • Linner A, Darenberg J, Sjolin J, et al (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851–7 [CrossRef] [PubMed] [Google Scholar]
  • Dumitrescu O, Boisset S, Badiou C, et al (2007) Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 51:1515–9 [CrossRef] [PubMed] [Google Scholar]
  • Nathwani D, Morgan M, Masterton RG, et al (2008) Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61:976–94 [CrossRef] [PubMed] [Google Scholar]
  • Morgan MS (2007) Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 30:289–96 [Google Scholar]
  • Wang J, McQuilten ZK, Wood EM, Aubron C (2015) Intravenous immunoglobulin in critically ill adults: When and what is the evidence? J Crit Care 30:652.e9–16 [CrossRef] [Google Scholar]
  • Gauduchon V, Cozon G, Vandenesch F, et al (2004) Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189:346–53 [CrossRef] [PubMed] [Google Scholar]
  • Honore PM, Joannes-Boyau O, Boer W, Collin V (2009) High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood purification 28:1–11 [CrossRef] [PubMed] [Google Scholar]
  • Ratanarat R, Brendolan A, Piccinni P, et al (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:R294–302 [CrossRef] [PubMed] [Google Scholar]
  • Swoboda S, Ober MC, Lichtenstern C, et al (2010) Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol 66:291–8 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.